Navigation Links
Lilly Confirms Date and Conference Call for Third-Quarter 2017 Financial Results Announcement
Date:10/2/2017

INDIANAPOLIS, Oct. 2, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its financial results for the third quarter of 2017 on Tuesday, October 24, 2017. Lilly will also conduct a conference call on that day with the investment community and media to further detail the company's financial performance.

The conference call will begin at 9 a.m. Eastern time. Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at https://investor.lilly.com/events.cfm. A replay will also be available on the website following the conference call.

About Eli Lilly and Company Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels. F-LLY

Refer to: Lauren Zierke; lauren_zierke@lilly.com; (317) 277-6524 (Media) Phil Johnson; johnson_philip_l@lilly.com; (317) 655-6874 (Investors)

View original content with multimedia:http://www.prnewswire.com/news-releases/lilly-confirms-date-and-conference-call-for-third-quarter-2017-financial-results-announcement-300529057.html


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. IHC 2017: Lillys Lasmiditan Significantly Reduces Pain in Patients with Migraine
2. Lilly Takes Steps to Streamline Business, Invest in New Medicines and Drive Growth
3. Lilly to Present New Data for Galcanezumab and Lasmiditan at the 18th Congress of the International Headache Society (IHC)
4. Lilly Reaches Settlement Agreement in U.S. Cialis Patent Litigation
5. Lillys Galcanezumab Significantly Reduces Number of Migraine Headache Days for Patients with Migraine: New Results Presented at AHS
6. IDF, in partnership with Lilly, announces second phase of BRIDGES programme funding for translational research in diabetes with focus on secondary prevention
7. Lilly Builds Upon Body of Data for Abemaciclib with Phase 3 MONARCH 2 Data Demonstrating Superior Progression-Free Survival in Advanced Breast Cancer
8. Lilly Confirms Date and Conference Call for First-Quarter 2017 Financial Results Announcement
9. Eli Lilly Partnering Deals and Alliances 2010 to 2017
10. Lilly Announces $850 Million Investment in U.S. Capital Projects in 2017
11. Lilly and the William Sansum Diabetes Center announce a five-year research collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2019)... ... 11, 2019 , ... Healthcare Information Management Leader to Showcase ... content management solutions, will exhibit at the 2019 Indiana Medical Group Management Association ... , Conference attendees are encouraged to stop by booth #105 to speak with ...
(Date:7/11/2019)... ... July 11, 2019 , ... Twenty-one ... among Castle Connolly’s Top Doctors. All of these professionals are recognized as Atlanta’s ... physicians in the publication’s urology category and all of the physicians in the ...
(Date:7/10/2019)... ... July 10, 2019 , ... ... of California on behalf of hundreds of its doctor and scientist members ... medical doctors who recommend medical exemptions to vaccination and labeling them as “fraudulent.” ...
Breaking Medicine Technology:
(Date:7/12/2019)... YORK (PRWEB) , ... July 12, 2019 , ... ... the company has gained Full Recognition status for its diabetes prevention program from ... first Diabetes Prevention Program (DPP) provider to gain full recognition from CDC that ...
(Date:7/11/2019)... ... July 11, 2019 , ... The International ... with a range of features to further advance their mission of delivering technical ... manufacturing quality medicines for patients worldwide. The latest additions include a new ISPE ...
(Date:7/10/2019)... CHARLOTTE, N.C. (PRWEB) , ... July 10, 2019 ... ... brand (NYSE American: YCBD), has just announced that Olympians Lolo Jones and Kerri ... massive platform for cbdMD to provide CBD education and brand awareness to athletes, ...
(Date:7/9/2019)... , ... July 10, 2019 , ... ... the role of Client Services Manager and will lead the growing team of ... role at First Healthcare Compliance and look forward to further developing new healthcare ...
(Date:7/9/2019)... PARK, Md. (PRWEB) , ... July 09, 2019 , ... ... but according to Xiaoping Zhu, professor and chair in Veterinary Medicine at UMD, half ... it lays dormant in your body for the rest of your life and can ...
Breaking Medicine News(10 mins):